Quarterly repeat cycles of onabotulinumtoxinA in chronic migraine patients: the benefits of the prolonged treatment on the continuous responders and quality-of-life conversion rate in a real-life setting

Santoro, Antonio; Fontana, Andrea; Miscio, Anna M.; Zarrelli, Michele M.; Copetti, Massimiliano; Leone, Maurizio A.

doi:10.1007/s10072-017-3054-y

2753Accesses
27Citations
7Altmetric
0Mentions

Metrics

Quarterly repeat cycles of onabotulinumtoxinA in chronic migraine patients: the benefits of the prolonged treatment on the continuous responders and quality-of-life conversion rate in a real-life setting

Last updated: Fri, 30 Jan 2026 11:25:54 UTC

Accesses

Accesses is an approximate count of unique views and downloads. This number can fluctuate depending on multiple factors.

We update counts daily.

2753 Accesses

Citations

Citation counts are provided by Dimensions and depend on their data availability. Counts will update daily, once available.

27Citations

Altmetric

1 tweeters
52 Mendeley

Altmetric calculates a score based on the online attention an article gets — the higher the score, the more online attention an article has received.

Surrounding the score can be 1 or more colours. Each colour represents a different type of online attention, like social media or news outlets.

Older articles have had more time to get noticed, so Altmetric provides context data for articles of a similar age.

This article is in the 73^rd percentile (ranked 88,211^th) of the 335,325 tracked articles of a similar age in all journals and the 84^th percentile (ranked 7^th) of the 45 tracked articles of a similar age in Neurological Sciences.

View more on Altmetric.

Back to article page